Pharmafile Logo
Pharmafocus logo
Advanced Search

Business Services

Pharmaceutical Business Services – News, analysis and company profiles

Showing 15 posts of 2453 posts found.

leipzig_skyline

FlyPharma Conference Europe: New dates and location announced

April 4, 2022 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

FlyPharma Conferences are pleased to announce that FlyPharma Europe is returning as a live, in-person event in 2022.
News

FDA approval of Cabenuva for adolescents living with HIV

March 31, 2022 Business Services

ViiV Healthcare, the global specialist HIV company, today announced the FDA approval of Cabenuva (cabotegravir, rilpivirine), for the treatment of …
News

Carteyva receives IND approval for clinical trial in second-line large b-cell lymphoma

March 31, 2022 Business Services

An investigational new drug (IND) clearance from the National Medical Products Administration (NMPA) of China, for a pivotal clinical trial …
News

250,000 with diabetes to benefit from real time information after updated NICE recommendations

March 31, 2022 Business Services

Over 250,000 people living with type 1 diabetes are set to be offered new technology to help them manage their …
News

Kesimpta-treated adults with multiple sclerosis not at risk of severe COVID-19

March 30, 2022 Business Services

The peer-reviewed journal Neurology and Therapy has published new data on COVID-19 infections in people living with remitting multiple sclerosis …
News

Carthera’s SonoCloud demonstrates potential in Alzheimer’s patients

March 30, 2022 Business Services

Carthera has announced the publication of results in the Alzheimer’s Research & Therapy Journal, from an investigator-sponsored trial evaluating the …
News

AstraZeneca cervical cancer treatment fails to meet endpoint in Phase III trial

March 24, 2022 Business Services

AstraZeneca has shared that results from its Calla Phase III trial of Imfinzi for the treatment of locally advanced cervical …
News

Novel therapy could revolutionise treatment for asthma, COPD, among others

March 24, 2022 Business Services

A multicenter research team in Texas has developed the first drug to treat the uncontrolled secretion of mucins in the …
News

FDA approval for castration-resistant prostate cancer

March 24, 2022 Business Services

The FDA has approved Novartis’ prostate cancer treatment, Pluvicto™, which is now expected to become available in a few weeks. …
News
guy_photo_2022_002

Ipsen appoints Guy Oliver as General Manager, UK & Ireland

March 21, 2022 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Ipsen have announced the appointment of Guy Oliver as General Manager of its UK and Ireland affiliate. Guy brings a …
Appointment

Global COVID-19 cases up for first time in weeks

March 17, 2022 Business Services

After more than a month of decline, global cases of COVID-19 have increased. WHO have stated that cases of the …
News

War in Ukraine could worsen COVID-19 pandemic, says WHO

March 17, 2022 Business Services

WHO has expressed concern that the war in Ukraine could worsen the COVID-19 pandemic, and it is aiming to do …
News

Ukraine: Health facilities a “target” of war

March 17, 2022 Business Services

Healthcare facilities have become a “target” of war, WHO has said, warning that the health system in Ukraine is “teetering …
News

Targeted drug Olaparib improves survival in early-stage breast cancer

March 17, 2022 Business Services

The Institute of Cancer Research (ICR), London, has reported new findings that the targeted drug olaparib improves survival in women …
News

Domain Therapeutics and Explicyte enter immuno-oncology partnership

March 10, 2022 Business Services

Domain Therapeutics and Explicyte have announced the signing of a partnership agreement. The two companies aim to combine their expertise …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025